BioSpace News Archive

Alcon announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery.

Fotona’s Cutting Edge Dynamis Laser System Earns Industry First Clearance

Certification confirms Viralgen’s commitment to high operational standards with the world’s most flexible and robust AAV manufacturing capability

LAIX Inc. announced its unaudited financial results for the second quarter ended June 30, 2019.

AMN Healthcare, the leader and innovator in healthcare workforce solutions and staffing services, has named Christine Mackey-Ross as Lead Executive Partner of Phillips DiPisa, an AMN Healthcare company.

REGENXBIO Inc. announced that an interim trial update from the RGX-314 Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration will be reported during a presentation at the Retina Subspecialty Day program of the American Academy of Ophthalmology 2019 Annual Meeting in San Francisco, CA.

Antibe Therapeutics Inc. provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346.

Interface Fluidics is a Calgary based laboratory service company with a nanotechnology platform for optimizing oil production and visualizing fluid-fluid interactions, through rapid chemical testing at reservoir temperature and pressure.

Catalent, Inc. announced financial results for the fourth quarter of fiscal year 2019, which ended June 30, 2019.

AbbVie, a research-based global biopharmaceutical company, will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019.